Table 3 Characteristics of patients with NSAID hypersensitivity and basal serum tryptase level > 20 ng/mL
Patient | Age, sex | Drug | Application | Latency [minutes] | Anaphylaxis [grade] | Treatment | Tryptase [ng/mL] | Classification of Mastocytosis |
|---|---|---|---|---|---|---|---|---|
#1 | 54, f | Acetylsalicylic acid | Oral | 15 | 1 | H1-blocker | 39.7 | ISM |
#2 | 61, f | Acetylsalicylic acid | Oral | 30 | 1 | No | 42.2 | ISM |
#3 | 72, f | Metamizol | Oral | 20 | 1 | No | 23.5 | CM |
#4 | 54, f | Diclofenac | Oral | 20 | 1 | No | 32.7 | n.d. |
#5 | 37, f | Acetylsalicylic acid | Oral | 30 | 2 | H1-blocker, steroids | 26.2 | n.d. |
#6 | 71, f | Diclofenac | Oral | 10 | 2 | H1-blocker | 94.8 | ISM |